Replies to post #233 on Javelin Pharmaceuticals Inc (JAV)

[Bio_pete]

That was pretty funny. I mentioned BDSI on the biotech value board and no one responded. Have you ever looked at the company? They signed a nice partnership agreement today with MEDA. $30 million upfront and another $30 million on FDA approval. Only $79 million market cap. BDSI plans to file an NDA this qtr. and MEDA is pursuing an EU application.

http://www.meda.se/english/news/year_2007/meda_acquires_exclusive_rights.pdf